Browse
S-Space
College of Medicine/School of Medicine (의과대학/대학원)
Dermatology (피부과학전공)
Journal Papers (저널논문_피부과학전공)
Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals
DC Field | Value | Language |
---|---|---|
dc.contributor.author | An, Susun | - |
dc.contributor.author | Kim, Seoyoung | - |
dc.contributor.author | Huh, Yong | - |
dc.contributor.author | Lee, Tae Ryong | - |
dc.contributor.author | Park, Kui-Lea | - |
dc.contributor.author | Eun, Hee Chul | - |
dc.contributor.author | Kim, Han-Kon | - |
dc.date.accessioned | 2012-07-03T01:27:24Z | - |
dc.date.available | 2012-07-03T01:27:24Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | CONTACT DERMATITIS; Vol.60(4); 185-192 | ko_KR |
dc.identifier.issn | 0105-1873 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78175 | - |
dc.description.abstract | Background: Evaluation of skin sensitization potential is an important part of the safety assessment of cosmetic ingredients and topical drugs. Recently, evaluation of changes in surface marker expression induced in dendritic cells (DC) or DC surrogate cell lines following exposure to chemicals represents one approach for in vitro test methods. Objective: The study aimed to test the change of expression patterns of surface markers on THP-1 cells by chemicals as a predictive in vitro method for contact sensitization. Methods: We investigated the expression of CD54, CD86, CD83, CD80, and CD40 after a 1-day exposure to sensitizers (1-chloro-2,4-dinitrobenzene; 2,4-dinitrofluorobenzene; benzocaine; 5-chloro-2-methyl-4-isothiazolin-3-one; hexyl cinnamic aldehyde; eugenol; nickel sulfate hexahydrate; potassium dichromate; cobalt sulfate; 2-mercaptobenzothiazole; and ammonium tetrachloroplatinate) and non-sensitizers (sodium lauryl sulfate, benzalkonium chloride, lactic acid, salicylic acid, isopropanol, and dimethyl sulphoxide). The test concentrations were 0.1 X, 0.5 X, and 1 X of the 50% inhibitory concentration, and the relative fluorescence intensity was used as an expression indicator. Result and Conclusion: By evaluating the expression patterns of CD54, CD86, and CD40, we could classify the chemicals as sensitizers or non-sensitizers, but CD80 and CD83 showed non-specific patterns of expression. These data suggest that the THP-1 cells are good model for screening contact sensitizers and CD40 could be a useful marker complementary to CD54 and CD86. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | WILEY-BLACKWELL PUBLISHING, INC | ko_KR |
dc.subject | CD40 | ko_KR |
dc.subject | in vitro skin sensitization | ko_KR |
dc.subject | THP-1 cell line | ko_KR |
dc.subject | CD86 | ko_KR |
dc.subject | CD54 | ko_KR |
dc.subject | CD80 | ko_KR |
dc.subject | CD83 | ko_KR |
dc.title | Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 안수선 | - |
dc.contributor.AlternativeAuthor | 김서영 | - |
dc.contributor.AlternativeAuthor | 허용 | - |
dc.contributor.AlternativeAuthor | 이태룡 | - |
dc.contributor.AlternativeAuthor | 김한곤 | - |
dc.contributor.AlternativeAuthor | 박귀리 | - |
dc.contributor.AlternativeAuthor | 은희철 | - |
dc.identifier.doi | 10.1111/j.1600-0536.2009.01528.x | - |
dc.citation.journaltitle | CONTACT DERMATITIS | - |
dc.description.citedreference | Rasaiyaah J, 2007, BRIT J HAEMATOL, V138, P281, DOI 10.1111/j.1365-2141.2007.06622.x | - |
dc.description.citedreference | Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026 | - |
dc.description.citedreference | Bocchietto E, 2007, INT J IMMUNOPATH PH, V20, P259 | - |
dc.description.citedreference | Sakaguchi H, 2007, ARCH DERMATOL RES, V298, P427, DOI 10.1007/s00403-006-0714-9 | - |
dc.description.citedreference | Ciabattini A, 2006, CLIN VACCINE IMMUNOL, V13, P1037, DOI 10.1128/CVI.00110-06 | - |
dc.description.citedreference | Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014 | - |
dc.description.citedreference | Azam P, 2006, TOXICOL APPL PHARM, V212, P14, DOI 10.1016/j.taap.2005.06.018 | - |
dc.description.citedreference | Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171 | - |
dc.description.citedreference | Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741 | - |
dc.description.citedreference | Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213 | - |
dc.description.citedreference | Galdiero M, 2004, MICROBIOLOGICA, V27, P309 | - |
dc.description.citedreference | Rustemeyer T, 2003, EXP DERMATOL, V12, P682 | - |
dc.description.citedreference | Yoshida Y, 2003, TOXICOL IN VITRO, V17, P221, DOI 10.1016/S0887-2333(03)00006-7 | - |
dc.description.citedreference | Ashikaga T, 2002, TOXICOL IN VITRO, V16, P711 | - |
dc.description.citedreference | Hulette BC, 2002, TOXICOL APPL PHARM, V182, P226, DOI 10.1006/taap.2002.9447 | - |
dc.description.citedreference | Cumberbatch M, 2000, CLIN EXP DERMATOL, V25, P413 | - |
dc.description.citedreference | Coutant KD, 1999, TOXICOL SCI, V52, P189 | - |
dc.description.citedreference | *NAT TOX PROGR, 1999, NIH PUBL | - |
dc.description.citedreference | Aiba S, 1997, EUR J IMMUNOL, V27, P3031 | - |
dc.description.citedreference | Krasteva M, 1996, CLIN EXP ALLERGY, V26, P563 | - |
dc.description.citedreference | BASKETTER DA, 1994, FOOD CHEM TOXICOL, V32, P543 | - |
dc.description.citedreference | MOULON C, 1993, IMMUNOLOGY, V80, P373 | - |
dc.description.citedreference | ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- College of Medicine/School of Medicine (의과대학/대학원)Dermatology (피부과학전공)Journal Papers (저널논문_피부과학전공)
- Files in This Item: There are no files associated with this item.
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.